These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12495790)

  • 21. Psychiatric factors affecting recovery after a long term treatment program for substance use disorder.
    Daigre C; Perea-Ortueta M; Berenguer M; Esculies O; Sorribes-Puertas M; Palma-Alvarez R; Martínez-Luna N; Ramos-Quiroga JA; Grau-López L
    Psychiatry Res; 2019 Jun; 276():283-289. PubMed ID: 31128488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance abuse treatment duration for Medicaid versus commercial clients in a health maintenance organization.
    McFarland BH; Lynch FL; Freeborn DK; Green CA; Polen MR; Deck DD; Dickinson DM
    Med Care; 2006 Jun; 44(6):601-6. PubMed ID: 16708010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Explaining unexpected gender differences in hostility among persons seeking treatment for substance use disorders.
    Robinson EA; Brower KJ; Gomberg ES
    J Stud Alcohol; 2001 Sep; 62(5):667-74. PubMed ID: 11702806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment variables that predict completion of an adolescent substance abuse treatment program.
    Blood L; Cornwall A
    J Nerv Ment Dis; 1994 Jan; 182(1):14-9. PubMed ID: 8277295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retention predictors related to intensive outpatient programs for substance use disorders.
    Veach LJ; Remley TP; Kippers SM; Sorg JD
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):417-28. PubMed ID: 10976666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women and addiction: the importance of gender issues in substance abuse research.
    Tuchman E
    J Addict Dis; 2010 Apr; 29(2):127-38. PubMed ID: 20407972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of drug treatment completion among parole violators.
    Zanis DA; Coviello DM; Lloyd JJ; Nazar BL
    J Psychoactive Drugs; 2009 Jun; 41(2):173-80. PubMed ID: 19705679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Post-Treatment Employment for Individuals with Substance Use Disorders.
    Kim M; Leierer S; Jeon J
    Community Ment Health J; 2019 Oct; 55(7):1236-1245. PubMed ID: 31267298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.
    Satre DD; Mertens JR; Areán PA; Weisner C
    Addiction; 2004 Oct; 99(10):1286-97. PubMed ID: 15369567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing utilization of mental health and substance abuse services by American Indian men and women.
    Robin RW; Chester B; Rasmussen JK; Jaranson JM; Goldman D
    Psychiatr Serv; 1997 Jun; 48(6):826-32. PubMed ID: 9175194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in treatment-seeking Brazilian drug-dependent individuals.
    Zilberman ML; Hochgraf PB; Andrade AG
    Subst Abus; 2003 Mar; 24(1):17-25. PubMed ID: 12652092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predicting drop out from, and retention in, specialist drug treatment services: a case control study in the North West of England.
    Beynon CM; McMinn AM; Marr AJ
    BMC Public Health; 2008 May; 8():149. PubMed ID: 18460202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "This Treatment Can Really Help Me"-A Longitudinal Analysis of Treatment Readiness and Its Predictors in Patients Undergoing Alcohol and Drug Rehabilitation Treatment.
    Piontek D; Kurktschiev S; Kraus L; Hölscher S; Rist F; Heinz T; Scherbaum N; Bender S; Buchholz A
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1174-1181. PubMed ID: 28370023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental health indicator interaction in predicting substance abuse treatment outcomes in nevada.
    Greenfield L; Wolf-Branigin M
    Am J Drug Alcohol Abuse; 2009; 35(5):350-7. PubMed ID: 20180663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities in Substance Abuse Treatment Utilization Among Women with Intellectual Disability.
    Slayter E
    J Soc Work Disabil Rehabil; 2016; 15(2):96-115. PubMed ID: 26958802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.
    Krawczyk N; Feder KA; Saloner B; Crum RM; Kealhofer M; Mojtabai R
    Drug Alcohol Depend; 2017 Jun; 175():157-163. PubMed ID: 28432939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study.
    Grella CE; Joshi V
    Am J Drug Alcohol Abuse; 1999 Aug; 25(3):385-406. PubMed ID: 10473004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Women in residential drug treatment: differences by program type and pregnancy.
    Grella CE
    J Health Care Poor Underserved; 1999 May; 10(2):216-29. PubMed ID: 10224827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.